Hos patienter med sekundærhyperparathyreosis bør Renagel anvendes i forbindelse med flere andre behandlinger, der kan omfatte kalciumtilskud, 1, 25 – dihydroxy vitamin D3 eller et af dettes analoge stoffer for at sænke niveauerne af det intakte parathyroidhormon (iPTH).
In patients with secondary hyperparathyroidism Renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 – dihydroxy Vitamin D3 or one of its analogues to lower the intact parathyroid hormone (iPTH) levels.